Athletes with neurologic disease

Guidry, Andrew; Crutchfield, Kevin E.

doi:10.1016/b978-0-444-63954-7.00041-0

Cited by 1 publication

(1 citation statement)

References 86 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In athletes, the prevalence of PTH has been reported to be as high as 93% after sports-related concussion and it is thought that this is the most common PCS symptom [ 1 , 2 ]. Most of the reports agree in regarding the prevalence of PTH in sports-related concussion [ 44 , 45 , 46 ]. Moreover, even amateur athletics activities were reported to produce TBIs (in almost 20% of the adults) [ 13 ].…”

Section: Prevalence Of Post-traumatic Headachesmentioning

confidence: 99%

Post-Traumatic Headache: A Review of Prevalence, Clinical Features, Risk Factors, and Treatment Strategies

Mavroudis

Ciobîcă

Luca

et al. 2023

JCM

View full text Add to dashboard Cite

Post-traumatic headache (PTH) is a common and debilitating consequence of mild traumatic brain injury (mTBI) that can occur over one year after the head impact event. Thus, better understanding of the underlying pathophysiology and risk factors could facilitate early identification and management of PTH. There are several factors that could influence the reporting of PTH prevalence, including the definition of concussion and PTH. The main risk factors for PTHs include a history of migraines or headaches, female gender, younger age, greater severity of the head injury, and co-occurring psychological symptoms, such as anxiety and depression. PTH clinical profiles vary based on onset, duration, and severity: tension-type headache, migraine headaches, cervicogenic headache, occipital neuralgia, and new daily persistent headache. Pharmacological treatments often consist of analgesics and non-steroidal anti-inflammatory drugs, tricyclic antidepressants, or antiepileptic medication. Cognitive behavioral therapy, relaxation techniques, biofeedback, and physical therapy could also be used for PTH treatment. Our work highlighted the need for more rigorous studies to better describe the importance of identifying risk factors and patient-centered treatments and to evaluate the effectiveness of the existing treatment options. Clinicians should consider a multidisciplinary approach to managing PTH, including pharmacotherapy, cognitive behavioral therapy, and lifestyle changes.

show abstract